Association between FCM score and cytogenetics in LGw/oRS patients
. | Cytogenetics, no.* . | . | . | Patients with abnormal cytogenetics, no.† . | . | . | . | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Abnormal . | Normal . | No metaphases . | +8 . | del(20q) . | der(1;7) . | Others . | |||||
| All patients | 16 | 10 | 1 | 4 | 4 | 3 | 5 | |||||
| FCM score | ||||||||||||
| 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | |||||
| 1 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | |||||
| 2 | 4 | 2 | 0 | 2 | 2 | 0 | 0 | |||||
| 3 | 3 | 3 | 0 | 0 | 1 | 0 | 2 | |||||
| 4 | 3 | 1 | 0 | 0 | 0 | 1 | 1 | |||||
| 5 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | |||||
| 6 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
| 7 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
| 3 or higher | 10 | 5 | 1 | 1 | 1 | 3 | 5 | |||||
. | Cytogenetics, no.* . | . | . | Patients with abnormal cytogenetics, no.† . | . | . | . | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Abnormal . | Normal . | No metaphases . | +8 . | del(20q) . | der(1;7) . | Others . | |||||
| All patients | 16 | 10 | 1 | 4 | 4 | 3 | 5 | |||||
| FCM score | ||||||||||||
| 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | |||||
| 1 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | |||||
| 2 | 4 | 2 | 0 | 2 | 2 | 0 | 0 | |||||
| 3 | 3 | 3 | 0 | 0 | 1 | 0 | 2 | |||||
| 4 | 3 | 1 | 0 | 0 | 0 | 1 | 1 | |||||
| 5 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | |||||
| 6 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
| 7 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
| 3 or higher | 10 | 5 | 1 | 1 | 1 | 3 | 5 | |||||
Data are number of patients. Patients with +8, del(20q), and der(1;7) included those with additional cytogenetic aberrations.
Abnormal vs normal, P = .530 (proportions of patients with FCM scores of 3 or higher are compared).
+8 or del(20q) vs others, P = .002 (proportions of patients with FCM scores of 3 or higher are compared).